Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Marpai, Inc. (MRAI : OTC)
 
 • Company Description   
Marpai Inc. is an AI-driven health tech company transforming third party administration in the self-funded market. Marpai Inc. is based in TAMPA, Fla.

Number of Employees: 117

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.45 Daily Weekly Monthly
20 Day Moving Average: 25,763 shares
Shares Outstanding: 18.46 (millions)
Market Capitalization: $26.76 (millions)
Beta: 4.60
52 Week High: $1.78
52 Week Low: $0.68
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.69% -1.14%
12 Week 9.85% 1.82%
Year To Date 52.63% 36.12%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
615 Channelside Drive Suite 207
-
Tampa,FL 33602
USA
ph: 855-389-7330
fax: -
steve.johnson@marpaihealth.com http://www.marpaihealth.com
 
 • General Corporate Information   
Officers
Damien Lamendola - Chief Executive Officer and Director
Yaron Eitan - Chairman of the Board of Directors
John Powers - President & Chief Operating Officer
Steve Johnson - Chief Financial Officer
Sagiv Shiv - Director

Peer Information
Marpai, Inc. (EVOL)
Marpai, Inc. (RAMP)
Marpai, Inc. (LGTY)
Marpai, Inc. (ALOT)
Marpai, Inc. (CXT)
Marpai, Inc. (TGHI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 571354208
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/10/25
Share - Related Items
Shares Outstanding: 18.46
Most Recent Split Date: 6.00 (0.25:1)
Beta: 4.60
Market Capitalization: $26.76 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/10/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 1.13
EPS Growth
vs. Year Ago Period: 77.24%
vs. Previous Quarter: -33.33%
Sales Growth
vs. Year Ago Period: -35.23%
vs. Previous Quarter: -14.06%
ROE
09/30/25 - -
06/30/25 - -
03/31/25 - -
ROA
09/30/25 - -
06/30/25 - -91.11
03/31/25 - -126.85
Current Ratio
09/30/25 - -
06/30/25 - 0.52
03/31/25 - 0.65
Quick Ratio
09/30/25 - -
06/30/25 - 0.52
03/31/25 - 0.65
Operating Margin
09/30/25 - -
06/30/25 - -55.10
03/31/25 - -82.80
Net Margin
09/30/25 - -
06/30/25 - -51.35
03/31/25 - -79.41
Pre-Tax Margin
09/30/25 - -
06/30/25 - -56.38
03/31/25 - -83.95
Book Value
09/30/25 - -
06/30/25 - -1.94
03/31/25 - -2.03
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Capital
09/30/25 - -
06/30/25 - -
03/31/25 - -
 

Powered by Zacks Investment Research ©